Clinical trial
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
NCT01569178 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
- Lead sponsor
- Queen Mary University of London
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- November 27, 2019
- Enrollment
- 375 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.